• Revenue up 25% to $8.27 million
• EBITDA up 33% to $2.01 million
• NPAT up 36% to $1.14 million
• Acquired new freehold facility to double storage capacity

Cryosite Limited has reported a strong financial performance for the half-year ended 31 December 2025, with revenue increasing by 25% to $8.27 million, EBITDA up 33% to $2.01 million, and net profit after tax (NPAT) rising 36% to $1.14 million. The company's operational volumes increased by 30% year-on-year, and it maintained industry-leading quality metrics. Cryosite completed the acquisition of a new freehold facility at 100-104 Adderley St West, Auburn, NSW, which more than doubles the group's usable storage and warehousing footprint to over 4,200 square meters. This acquisition was funded through a combination of operating cashflows and a debt facility from the National Australia Bank. The company also commenced construction works to expand the primary large-scale cool room (2°C to 8°C) at its Ferndell St facility. These expansion projects are progressing on time and on budget and are funded from operating cashflows. Cryosite remains in a strong financial position, with cash on hand of $2.54 million as of 31 December 2025. The company's growth and momentum are the result of trusted client relationships, disciplined execution by the team, and the continued backing of shareholders.

For the financial year ending 30 June 2026, Cryosite expects to deliver revenue growth of 20-25% and EBITDA growth of 25-30% compared to the prior year.

Cryosite is well-positioned to continue its strong growth trajectory, driven by increasing demand for its specialized, temperature-controlled logistics and depot services across the regulated pharmaceutical and advanced therapy sectors. The company's recent capacity expansions provide critical infrastructure to support this growth, and Cryosite remains focused on reinvesting in high-return opportunities while maintaining balance sheet flexibility.